Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$90.5M |
| 2 |
SW
Smurfit Westrock
SW
|
+$70M |
| 3 |
Pinduoduo
PDD
|
+$28.2M |
| 4 |
Microsoft
MSFT
|
+$24.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$118M |
| 2 |
Apple
AAPL
|
+$43.5M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$27.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.62% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.21% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Southside Bancshares
SBSI
$984M
| $1.89M | ﹤0.01% |
56,618
| – | – |
|
1902
Vicor
VICR
$10.4B
| $1.89M | ﹤0.01% |
44,832
| – | – |
|
1903
Travere Therapeutics
TVTX
$5.79B
| $1.88M | ﹤0.01% |
134,700
| – | – |
|
|
EXK
1904
Endeavour Silver
EXK
$3.05B
| $1.88M | ﹤0.01% |
476,100
| – | – |
|
1905
Shoals Technologies Group
SHLS
$1.37B
| $1.88M | ﹤0.01% |
334,900
| – | – |
|
|
FBMS
1906
DELISTED
The First Bancshares, Inc.
FBMS
| $1.88M | ﹤0.01% |
58,430
| – | – |
|
1907
Kimbell Royalty Partners
KRP
$1.52B
| $1.88M | ﹤0.01% |
116,600
-6,900
| -6% | -$111K |
|
|
DX
1908
Dynex Capital
DX
$3.23B
| $1.87M | ﹤0.01% |
146,933
| – | – |
|
1909
XPEL
XPEL
$1.39B
| $1.87M | ﹤0.01% |
43,200
-400
| -0.9% | -$16.1K |
|
1910
FTAI Infrastructure
FIP
$551M
| $1.87M | ﹤0.01% |
200,100
| – | – |
|
1911
Revolve Group
RVLV
$1.72B
| $1.86M | ﹤0.01% |
75,200
| – | – |
|
1912
Origin Bancorp
OBK
$1.69B
| $1.86M | ﹤0.01% |
57,782
| – | – |
|
1913
Janux Therapeutics
JANX
$978M
| $1.85M | ﹤0.01% |
40,700
| – | – |
|
1914
Driven Brands
DRVN
$2.12B
| $1.85M | ﹤0.01% |
129,400
| – | – |
|
|
BDN
1915
Brandywine Realty Trust
BDN
$542M
| $1.85M | ﹤0.01% |
339,200
| – | – |
|
|
SII
1916
Sprott
SII
$3.03B
| $1.84M | ﹤0.01% |
42,475
-1,400
| -3% | -$59.2K |
|
1917
Globalstar
GSAT
$10.7B
| $1.84M | ﹤0.01% |
98,904
-1,133
| -1% | -$21K |
|
1918
Maravai LifeSciences
MRVI
$861M
| $1.84M | ﹤0.01% |
221,000
| – | – |
|
1919
Lifestance Health
LFST
$4.67B
| $1.83M | ﹤0.01% |
261,400
+36,700
| +16% | +$221K |
|
|
SLNO
1920
DELISTED
Soleno Therapeutics
SLNO
| $1.82M | ﹤0.01% |
36,000
+7,200
| +25% | +$345K |
|
|
PLYM
1921
DELISTED
Plymouth Industrial REIT
PLYM
| $1.82M | ﹤0.01% |
80,400
| – | – |
|
1922
Mativ Holdings
MATV
$667M
| $1.81M | ﹤0.01% |
106,812
| – | – |
|
1923
AMERISAFE
AMSF
$504M
| $1.81M | ﹤0.01% |
37,400
-400
| -1% | -$19K |
|
1924
Merchants Bancorp
MBIN
$2.54B
| $1.81M | ﹤0.01% |
40,200
+6,100
| +18% | +$271K |
|
1925
Seaboard Corp
SEB
$4.08B
| $1.8M | ﹤0.01% |
574
| – | – |
|
Similar funds
Swiss National Bank's Q3 2024 Portfolio in Review
As of Q3 2024, Swiss National Bank held 2,510 positions worth $154B, up 5.8% from $146B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.9%. Swiss National Bank opened 52 new positions and exited 45, leaving the 2,510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2024 buy was Nu Holdings: 6,729,657 shares worth $91.9M.
- Swiss National Bank added most to Pinduoduo in Q3 2024, an estimated $28.2M increase.
- Swiss National Bank's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $118M.
- Swiss National Bank fully exited WestRock Company in Q3 2024, selling an estimated $38.2M.
- Swiss National Bank's ten largest holdings make up 32% of its $154B portfolio in Q3 2024.
- Swiss National Bank opened 52 new positions and closed 45 in Q3 2024.
- Swiss National Bank's portfolio value rose 5.8% quarter-over-quarter to $154B.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.